Research and Development
About
The Research and Development team at Tubulis is responsible for pioneering the creation and optimization of protein-drug conjugates. This team combines expertise in bioconjugation, bioanalytics, biology, toxicology, chemistry, and biomarker development to advance the therapeutic efficacy and safety of antibody-drug conjugates (ADCs). Their work includes discovering and developing novel conjugates, addressing development challenges, and collaborating with partners to maximize the potential of both antibody and chemical assets for better patient outcomes.